SCHEMBL26329797

SCHEMBL26329797

c1ccc(-n2c3ccccc3c3cc4c5ccccc5n(-c5ccc6c(c5)c5cnccc5n6-c5ccc6ccccc6c5)c4cc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAOA P21397 4/20 0.39
MAOB P27338 4/20 0.39
ACHE P22303 1/20 0.39
MAPK10 P53779 9/20 0.38
MAPK9 P45984 8/20 0.38
CDK4 P11802 1/20 0.37
CDK6 Q00534 1/20 0.37
MAPK8 P45983 1/20 0.36
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26329798 1.00 KDM4E (0.43) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL26329779 0.93 KDM4E (0.50) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL26329806 0.93 KDM4E (0.50) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL26329807 0.93 KDM4E (0.50) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL17349393 0.91 KDM4E (0.43) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL26329869 0.91 KDM4E (0.40) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL26329874 0.91 KDM4E (0.40) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL18958430 0.90 MAPK10 (0.41) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL18958713 0.90 MAPK10 (0.41) KDM4EATML3MBTL1MAOAMAOB
SCHEMBL26329842 0.89 KDM4E (0.44) KDM4EATML3MBTL1MAPK10MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11723269-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-08 US disclosed
US-11723269-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11723269-B2 Organic electroluminescent materials and devices PUF60, CD99, DDT KDM4E 3163/4885ATM 3362/4885L3MBTL1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.